Joshua N Liberman

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Glycemic Control

Major Depressive Disorder

Top Venues

Expert review of pharmacoeconomics & outcomes research

Psychiatric research and clinical practice

ClinicoEconomics and outcomes research : CEOR

Health services research and managerial epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Felicia Forma, Joshua N Liberman, Pinyao Rui, Charles Ruetsch
Adherence to augmentation therapy for the treatment of major depressive disorder. Expert review of pharmacoeconomics & outcomes research 23 (3) (2023)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Felicia Forma, Joshua N Liberman, Pinyao Rui, Charles Ruetsch
Adherence to augmentation therapy for the treatment of major depressive disorder. Expert review of pharmacoeconomics & outcomes research 23 (3) (2023)
Felicia Forma, Joshua N Liberman, Pinyao Rui, Charles Ruetsch
Adherence to augmentation therapy for the treatment of major depressive disorder. Expert review of pharmacoeconomics & outcomes research (2023)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Felicia Forma, Joshua N Liberman, Pinyao Rui, Charles Ruetsch
Adherence to augmentation therapy for the treatment of major depressive disorder. Expert review of pharmacoeconomics & outcomes research (2023)
Joshua N Liberman, Jacqueline Pesa, Pinyao Rui, Amanda Teeple, Susan Lakey, Emily Wiggins, Brian Ahmedani
Predicting Poor Outcomes Among Individuals Seeking Care for Major Depressive Disorder. Psychiatric research and clinical practice 4 (4) (2022)
Joshua N Liberman, Jacqueline Pesa, Pinyao Rui, Amanda Teeple, Susan Lakey, Emily Wiggins, Brian Ahmedani
Predicting Poor Outcomes Among Individuals Seeking Care for Major Depressive Disorder. Psychiatric research and clinical practice 4 (4) (2022)
Joshua N Liberman, Sandipan Bhattacharjee, Pinyao Rui, Charles Ruetsch, Brian Rothman, Amit Kulkarni, Felicia Forma
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder. Health services research and managerial epidemiology 9 (2022)
Joshua N Liberman, Tigwa Davis, Dawn Velligan, Delbert Robinson, William Carpenter, Chris Jaeger, Heidi Waters, Charles Ruetsch, Felicia Forma
Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence. Psychiatric research and clinical practice 4 (2) (2022)